A Study of Secutrelvir in Participants With Coronavirus Disease 2019 (COVID-19) Who Are at High Risk for Progression to Severe Disease
Public ClinicalTrials.gov record NCT07743580. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3 Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Secutrelvir in Participants With COVID-19 Who Are at High Risk for Progression to Severe Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary purpose of this study is to evaluate the efficacy and safety of secutrelvir in symptomatic nonhospitalized adult and adolescent participants with COVID-19 who are at high risk for progression to severe disease.
Study identification
- NCT ID
- NCT07743580
- Recruitment status
- Recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 2,000 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 14, 2026 (Actual)
- Primary completion
- Jun 30, 2028 (Estimated)
- Completion
- Dec 31, 2028 (Estimated)
- Last update posted
- Oct 9, 2026
2026 – 2028
United States locations
- U.S. sites
- 9
- U.S. states
- 2
- U.S. cities
- 5
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Hope Clinical Trials - 3970 W Flagler St. | Coral Gables | Florida | 33134-1642 | Not yet recruiting |
| Continental Clinical Research, LLC | Miami | Florida | 33144-4273 | Not yet recruiting |
| Reed Medical Research | Miami | Florida | 33176-8709 | Not yet recruiting |
| Kendall South Medical Center Inc. | Miami | Florida | 33185-5948 | Not yet recruiting |
| Global Clinical Professionals | St. Petersburg | Florida | 33705 | Not yet recruiting |
| New Tampa Health | Tampa | Florida | 33603-3402 | Not yet recruiting |
| Research Bay, Inc. | Tampa | Florida | 33607 | Not yet recruiting |
| Hometown Urgent Care and Research | Cincinnati | Ohio | 45215-1170 | Not yet recruiting |
| Velocity Clinical Research | Cincinnati | Ohio | 45246 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 31 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT07743580, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 9, 2026 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT07743580 live on ClinicalTrials.gov.